Ginsenoside Rb1 inhibits fibrillation and toxicity of alpha-synuclein and disaggregates preformed fibrils
المؤلف | Ardah, Mustafa T. |
المؤلف | Paleologou, Katerina E. |
المؤلف | Lv, Guohua |
المؤلف | Menon, Sindhu A. |
المؤلف | Abul Khair, Salema B. |
المؤلف | Lu, Jia-Hong |
المؤلف | Safieh-Garabedian, Bared |
المؤلف | Al-Hayani, Abdulmonem A. |
المؤلف | Eliezer, David |
المؤلف | Li, Min |
المؤلف | El-Agnaf, Omar M.A. |
تاريخ الإتاحة | 2016-11-22T06:39:03Z |
تاريخ النشر | 2015-02-01 |
اسم المنشور | Neurobiology of Disease |
المعرّف | http://dx.doi.org/10.1016/j.nbd.2014.11.007 |
الاقتباس | Mustafa T. Ardah, Katerina E. Paleologou, Guohua Lv, Sindhu A. Menon, Salema B. Abul Khair, Jia-Hong Lu, Bared Safieh-Garabedian, Abdulmonem A. Al-Hayani, David Eliezer, Min Li, Omar M.A. El-Agnaf, Ginsenoside Rb1 inhibits fibrillation and toxicity of alpha-synuclein and disaggregates preformed fibrils, Neurobiology of Disease, Volume 74, February 2015, Pages 89-101 |
الرقم المعياري الدولي للكتاب | 09699961 |
الملخص | Compelling evidence indicates that α-synuclein (α-syn) aggregation plays a central role in the pathogenesis of Parkinson's disease (PD) and other synucleinopathies. Identification of compounds that inhibit or reverse the aggregation process may thus represent a viable therapeutic strategy against PD and related disorders. Ginseng is a well-known medicinal plant that has been used in East Asia for more than two thousand years to treat several conditions. It is now understood that the pharmacological properties of ginseng can be attributed to its biologically active components, the ginsenosides, which in turn have been shown to have neuroprotective properties. We therefore sought to determine for the first time, the potential of the most frequently used and studied ginsenosides, namely Rg1, Rg3 and Rb1, as anti-amyloidogenic agents. The effect of Rg1, Rg3 and Rb1 on α-syn aggregation and toxicity was determined by an array of biophysical, biochemical and cell-culture-based techniques. Among the screened ginsenosides, only Rb1 was shown to be a potent inhibitor of α-syn fibrillation and toxicity. Additionally, Rb1 exhibited a strong ability to disaggregate preformed fibrils and to inhibit the seeded polymerization of α-syn. Interestingly, Rb1 was found to stabilize soluble non-toxic oligomers with no β-sheet content, that were susceptible to proteinase K digestion, and the binding of Rb1 to those oligomers may represent a potential mechanism of action. Thus, Rb1 could represent the starting point for designing new molecules that could be utilized as drugs for the treatment of PD and related disorders. |
راعي المشروع | Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences (Dubai, UAE; Grant MRG-23/2005–2006). This study was made possible by NPRP grant 4-1371-1-223 from the Qatar National Research Fund (a member of Qatar Foundation). DE is also supported by NIH/NIA grant AG019391. MA was supported by United Arab Emirates University — PhD scholarship. |
اللغة | en |
الناشر | Elsevier |
الموضوع | α-Synuclein Parkinson's disease Aggregation Amyloid fibrils Ginsenosides Drug discovery |
النوع | Article |
الصفحات | 89-101 |
رقم المجلد | 74 |
تحقق من خيارات الوصول
الملفات في هذه التسجيلة
الملفات | الحجم | الصيغة | العرض |
---|---|---|---|
لا توجد ملفات لها صلة بهذه التسجيلة. |
هذه التسجيلة تظهر في المجموعات التالية
-
العلوم البيولوجية والبيئية [881 items ]